Delivery Order SPE2DB22D3501-SPE2DB25FWW30
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,705.28 to AmerisourceBergen Drug Corp for Omnipaque 350 mg/mL Pluspak 500mL, a contrast medium used in medical imaging procedures. This firm fixed price delivery order, which became effective on October 28, 2025, with a completion date of October 29, 2025, represents a small-value transaction under AmerisourceBergen's larger contract portfolio with the agency. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a $2,663.78 delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Omnipaque 300 mg/ml Pluspak 500ml, a contrast medium used in medical imaging procedures. This firm fixed-price delivery order is not set-aside and is scheduled for completion by November 10, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Omnipaque 350 mg/mL Pluspak 500mL, a contrast medium used in medical imaging procedures. Valued at $5,410.56 with a firm fixed price structure, this non-set-aside delivery order represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a $4,997.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Omnipaque 300 mg/ml contrast medium in 100ml infusion bottles. The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive set-aside delivery order for medical imaging supplies. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal healthcare systems,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Omnipaque 300 mg/mL Pluspak 500mL contrast media, with a contract ceiling value of $1,141.62. This is a firm fixed-price delivery order under a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This delivery order represents a...
- The Defense Logistics Agency awarded a $1,352.64 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Omnipaque 350 mg/ml Pluspak 500ml, a contrast medium used in medical imaging procedures. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 15, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's ability to compete...
- The Defense Logistics Agency awarded a $1,622.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for Omnipaque 300 mg/ml infusion bottles (100ml units). The contract, which is non-set-aside and competitively awarded, is scheduled for completion by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,043.44 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Omnipaque 350 mg/mL Pluspak 500ml, a contrast medium used in medical imaging procedures. This is a non-set-aside, competitively awarded contract with a completion date of June 17, 2025, and performance executed from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,235.01 to AmerisourceBergen Drug Corp for Omnipaque 300 mg/ml vials (10 ml) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Omnipaque is a contrast medium used in medical imaging procedures, reflecting the company's role as a critical...
- The Defense Logistics Agency awarded a $1,582.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Omnipaque 180 mg/mL vials (10 mL units) on August 20, 2025, with a completion date of August 21, 2025. This non-set-aside competitive award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWW30Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,814.91 to AmerisourceBergen Drug Corp for Omnipaque 300 mg/ml Pluspak 500ml, a contrast medium used in medical imaging procedures. This non-competitive, firm fixed-price delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's federal contract portfolio demonstrates significant capacity to fulfill diverse medical procurement requirements across multiple therapeutic domains, positioning the company as a critical pharmaceutical distributor within the military supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/14/25 |